Skip to content

INTERVAS CONSTRUCT: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

INTERVAS CONSTRUCT

BE 0761.451.879
NACE 43.990, Other specialised construction activities
latest balance sheet 30-06-2025indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€128,314 to €165,352

Midpoint €143,746 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity €71,434
Capitalised earnings €185,193 to €259,270
Indication €128,314 to €165,352

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€71,434
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€71,434

Capitalised earnings

net result for the year (9904)
2025
€58,936
2024
€21,347
2023
-€2,504
2022
-€6,846
Average result
€25,927
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€185,193 / €216,058 / €259,270

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 30 June 2025. Prepared on 28 September 2026 via checked.be. Indication, not a valuation or advice.